Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Nat Commun ; 11(1): 787, 2020 02 07.
Artigo em Inglês | MEDLINE | ID: mdl-32034161

RESUMO

Quantitative phosphoproteomics has transformed investigations of cell signaling, but it remains challenging to scale the technology for high-throughput analyses. Here we report a rapid and reproducible approach to analyze hundreds of phosphoproteomes using data-independent acquisition (DIA) with an accurate site localization score incorporated into Spectronaut. DIA-based phosphoproteomics achieves an order of magnitude broader dynamic range, higher reproducibility of identification, and improved sensitivity and accuracy of quantification compared to state-of-the-art data-dependent acquisition (DDA)-based phosphoproteomics. Notably, direct DIA without the need of spectral libraries performs close to analyses using project-specific libraries, quantifying > 20,000 phosphopeptides in 15 min single-shot LC-MS analysis per condition. Adaptation of a 3D multiple regression model-based algorithm enables global determination of phosphorylation site stoichiometry in DIA. Scalability of the DIA approach is demonstrated by systematically analyzing the effects of thirty kinase inhibitors in context of epidermal growth factor (EGF) signaling showing that specific protein kinases mediate EGF-dependent phospho-regulation.


Assuntos
Algoritmos , Biologia Computacional/métodos , Fosfopeptídeos/análise , Proteínas Quinases/metabolismo , Proteômica/métodos , Espectrometria de Massas em Tandem/métodos , Cromatografia Líquida/métodos , Fator de Crescimento Epidérmico/metabolismo , Células HeLa , Ensaios de Triagem em Larga Escala/métodos , Humanos , Fosfopeptídeos/metabolismo , Fosfoproteínas/análise , Fosforilação , Inibidores de Proteínas Quinases/farmacologia , Reprodutibilidade dos Testes
2.
Mol Omics ; 15(5): 348-360, 2019 10 07.
Artigo em Inglês | MEDLINE | ID: mdl-31465043

RESUMO

Comprehensive proteome quantification is crucial for a better understanding of underlying mechanisms of diseases. Liquid chromatography mass spectrometry (LC-MS) has become the method of choice for comprehensive proteome quantification due to its power and versatility. Even though great advances have been made in recent years, full proteome coverage for complex samples remains challenging due to the high dynamic range of protein expression. Additionally, when studying disease regulatory proteins, biomarkers or potential drug targets are often low abundant, such as for instance kinases and transcription factors. Here, we show that with improvements in chromatography and data analysis the single shot proteome coverage can go beyond 10 000 proteins in human tissue. In a testis cancer study, we quantified 11 200 proteins using data independent acquisition (DIA). This depth was achieved with a false discovery rate of 1% which was experimentally validated using a two species test. We introduce the concept of hybrid libraries which combines the strength of direct searching of DIA data as well as the use of large project-specific or published DDA data sets. Remarkably deep proteome coverage is possible using hybrid libraries without the additional burden of creating a project-specific library. Within the testis cancer set, we found a large proportion of proteins in an altered expression (in total: 3351; 1453 increased in cancer). Many of these proteins could be linked to the hallmarks of cancer. For example, the complement system was downregulated which helps to evade the immune response and chromosomal replication was upregulated indicating a dysregulated cell cycle.


Assuntos
Cromatografia Líquida/instrumentação , Espectrometria de Massas/instrumentação , Células-Tronco Neoplásicas/química , Proteômica/métodos , Cromatografia Líquida/métodos , Regulação Neoplásica da Expressão Gênica , Humanos , Masculino , Espectrometria de Massas/métodos , Células-Tronco Neoplásicas/metabolismo , Proteoma , Neoplasias Testiculares/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA